A private equity company bought an established producer of blood-based pharmaceuticals. With site management and 3 cross-functional teams of 40 employees in total we reviewed the complete value stream. Identifying, prioritizing and sequencing the identified 90 projects (from small to multi-year) we provided the plan to first double and in 3 years triple production without further production buildings. As a side-effect, people who worked 25+ years at the company noted: “Wow, we never before saw the links between our units so clearly!”